Your browser doesn't support javascript.
loading
Ulcerative Colitis Narrative Global Survey Findings: The Impact of Living With Ulcerative Colitis-Patients' and Physicians' View.
Dubinsky, Marla C; Watanabe, Kenji; Molander, Pauliina; Peyrin-Biroulet, Laurent; Rubin, Michele; Melmed, Gil Y; Deuring, J Jasper; Woolcott, John; Cappelleri, Joseph C; Steinberg, Kathy; Connor, Susan.
Afiliação
  • Dubinsky MC; Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Watanabe K; Hyogo College of Medicine, Hyogo, Japan.
  • Molander P; Abdominal Center, Gastroenterology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Peyrin-Biroulet L; Nancy University Hospital, Lorraine University, Vandœuvre-lès-Nancy, France.
  • Rubin M; University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, Illinois, USA.
  • Melmed GY; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Deuring JJ; Pfizer Inc, Rotterdam, The Netherlands.
  • Woolcott J; Pfizer Inc, Collegeville, Pennsylvania, USA.
  • Cappelleri JC; Pfizer Inc, Groton, Connecticut, USA.
  • Steinberg K; The Harris Poll, New York, New York, USA.
  • Connor S; Liverpool Hospital, South Western Sydney Clinical School, University of New South Wales, Ingham Institute of Applied Medical Research, Liverpool, New South Wales, Australia.
Inflamm Bowel Dis ; 27(11): 1747-1755, 2021 10 20.
Article em En | MEDLINE | ID: mdl-33529314
ABSTRACT

BACKGROUND:

The Ulcerative Colitis (UC) Narrative is a global patient and physician survey aimed at identifying the impact of UC and comparing and contrasting perceptions of UC burden and management approaches.

METHODS:

Surveys of patients with UC (self-reported diagnosis; n = 2100) and physicians (n = 1254) were completed across 10 countries by The Harris Poll between August 2017 and February 2018. Questionnaires covered multiple aspects of UC, including diagnosis, treatment, and impact on patient quality of life, in addition to standard demographic information. Descriptive statistics are reported.

RESULTS:

The majority of patients (82%) had moderate to severe UC (based on medication history; those who had only ever taken 5-aminosalicylates were excluded); 67% described their UC as controlled with few to no symptoms. On average, patients experienced 4.3 flares (standard deviation, 7.4) in the past year. Diagnostic delay was on average 2.0 years (standard deviation, 5.4); 42% of patients waited ≥1 year. Most patients (65%) felt that UC controlled their life rather than them controlling their disease. Because of the fear of repercussions, many patients had not disclosed their UC to their employer. Discussion of the emotional impact of UC during routine appointments was less of a priority for physicians, compared with patients.

CONCLUSIONS:

The data from this global survey highlight that patients with UC experience diagnostic delay, poor disease control, and adverse impact on their quality of life. Patients report UC to be a mentally exhausting condition; however, emotional and mental health issues are infrequently discussed at routine appointments.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Colite Ulcerativa Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Inflamm Bowel Dis Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Colite Ulcerativa Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Inflamm Bowel Dis Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos